Safety of Cabergoline for Postpartum Lactation Inhibition or Suppression: A Systematic Review-Reference-Cited by-同舟云学术

Safety of Cabergoline for Postpartum Lactation Inhibition or Suppression: A Systematic Review

Published:2020-03 Issue:3 Volume:42 Page:308-315.e20
ISSN:1701-2163
Container-title:Journal of Obstetrics and Gynaecology Canada
language:en
Short-container-title:Journal of Obstetrics and Gynaecology Canada

Author:

Harris Kristin^ORCID,Murphy Kellie E.,Horn Daphne,MacGilivray Jay,Yudin Mark H.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference35 articles.

1. Postpartum practice: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF);Senat;Eur J Obstet Gynecol Reprod Biol,2016

2. A retrospective drug use evaluation of cabergoline for lactation inhibition at a tertiary care teaching hospital in Qatar;AlSaad;Ther Clin Risk Manag,2016

3. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation;Rains;Drugs,1995

4. Treatments for suppression of lactation;Oladapo;Cochrane Database Syst Rev,2012

5. Pfizer Canada Inc. Dostinex Product Monograph. Last revised July 23, 2013. Available at: http://www.pfizer.ca/sites/g/files/g10017036/f/201410/Dostinex.pdf. Accessed on May 8 2019.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and structural elucidation of an oxidation product generated during stability studies of Cabergoline drug product;Journal of Pharmaceutical and Biomedical Analysis;2024-09

2. Comparing pyridoxine with dopaminergic agonists (cabergoline and bromocriptine): Unveiling the strategy for lactation inhibition - A systematic review of clinical trials;Journal of Gynecology Obstetrics and Human Reproduction;2024-06

3. Postpartum Psychosis: A Review of Risk Factors, Clinical Picture, Management, Prevention, and Psychosocial Determinants;Medical Science Monitor;2023-11-03

4. The efficiency of cabergoline vs pyridoxine for lactation inhibition—a randomized controlled trial;American Journal of Obstetrics and Gynecology;2023-10

5. Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Pregnancy Loss;Obstetrics & Gynecology;2023-05-03